Facebook
X
LinkedIn
ForwardRohan Khera, MD, MS
Dr. Khera is a Cardiologist and Data Scientist and the Director of the Cardiovascular Data Science (CarDS) Lab, which is a multidisciplinary group focusing on data-driven discovery in cardiovascular disease. He is the Clinical Director of the Center for Health Informatics and Analytics at the Yale Center for Outcomes Research and Evaluation. He is also an Associate Editor for Artificial Intelligence and Digital Health at JAMA.
The CarDS Lab, which Dr. Khera leads, is developing and implementing strategies to improve outcomes for patients with or at risk for cardiovascular disease through data-driven innovations in delivering evidence-based, patient-centered care. Dr. Khera’s work focuses on novel applications in artificial intelligence to evaluate patient care and develop precision care solutions. His work spans broad digital data sources, including electronic health records, electrocardiography, cardiovascular imaging, and wearable devices, with applications to modernize US and global healthcare. The work in his Lab is supported by grants from the National Institutes of Health and the Doris Duke Charitable Foundation.
Dr. Khera graduated from the All-India Institute of Medical Sciences as a National Young Investigator Scholarship awardee. During his training Dr. Khera received the American College of Cardiology’s Young Investigator Award and the Francois Abboud Young Investigator Award, in addition to being inducted into the Alpha Omega Alpha Medical Honor Society. For his work at Yale, Dr. Khera received the 2023 ASCI Young Physician-Scientist Award, the 2023 Blavatnik Award, and the 2021 Jeremiah Stamler Award.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Novo NordiskTopic:Research grant on healthcare resource utilization for patients with T2DMDate added:05/09/2025Date updated:05/09/2025Relationship end date:05/31/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BMS-PfizerTopic:Electronic quality of care measurement for patients taking DOACsDate added:05/09/2025Date updated:05/09/2025Relationship end date:10/10/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BridgeBioTopic:Multimodal AI screening for ATTR amyloidDate added:05/09/2025Date updated:05/09/2025Relationship end date:12/31/2026
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.